CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $250,290,000 | +117.8% | 4,844,951 | +4.5% | 0.01% | +125.0% |
| Q2 2022 | $114,922,000 | +6.7% | 4,637,652 | +8.0% | 0.00% | +33.3% |
| Q1 2022 | $107,658,000 | -31.7% | 4,294,335 | -0.7% | 0.00% | -25.0% |
| Q4 2021 | $157,527,000 | +108.0% | 4,326,487 | -2.3% | 0.00% | +100.0% |
| Q3 2021 | $75,728,000 | +21.4% | 4,428,554 | -5.0% | 0.00% | 0.0% |
| Q2 2021 | $62,389,000 | -75.5% | 4,659,397 | -6.4% | 0.00% | -71.4% |
| Q1 2021 | $255,000,000 | -14.3% | 4,976,595 | +3.6% | 0.01% | -22.2% |
| Q4 2020 | $297,507,000 | +21.4% | 4,804,697 | +7.4% | 0.01% | 0.0% |
| Q3 2020 | $245,087,000 | -0.7% | 4,472,434 | +4.3% | 0.01% | -10.0% |
| Q2 2020 | $246,724,000 | +57.1% | 4,287,884 | +9.7% | 0.01% | +25.0% |
| Q1 2020 | $157,064,000 | -3.4% | 3,908,984 | -5.0% | 0.01% | +33.3% |
| Q4 2019 | $162,676,000 | +490.1% | 4,113,156 | +1.2% | 0.01% | +500.0% |
| Q3 2019 | $27,567,000 | -23.1% | 4,065,911 | +5.5% | 0.00% | -50.0% |
| Q2 2019 | $35,832,000 | -2.7% | 3,852,875 | +45.4% | 0.00% | 0.0% |
| Q1 2019 | $36,820,000 | +23.6% | 2,650,720 | -2.9% | 0.00% | 0.0% |
| Q4 2018 | $29,782,000 | -15.9% | 2,729,701 | -2.6% | 0.00% | 0.0% |
| Q3 2018 | $35,425,000 | -1.2% | 2,802,721 | +3.0% | 0.00% | 0.0% |
| Q2 2018 | $35,847,000 | +2.7% | 2,721,938 | +6.0% | 0.00% | 0.0% |
| Q1 2018 | $34,909,000 | +113.9% | 2,566,766 | -6.4% | 0.00% | +100.0% |
| Q4 2017 | $16,318,000 | -20.7% | 2,742,607 | -1.1% | 0.00% | 0.0% |
| Q3 2017 | $20,585,000 | -5.6% | 2,774,193 | +19.1% | 0.00% | 0.0% |
| Q2 2017 | $21,807,000 | +39.0% | 2,329,816 | +8.1% | 0.00% | 0.0% |
| Q1 2017 | $15,692,000 | +13664.9% | 2,155,345 | +13873.1% | 0.00% | – |
| Q4 2016 | $114,000 | +470.0% | 15,425 | +369.4% | 0.00% | – |
| Q3 2016 | $20,000 | +42.9% | 3,286 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | +180.0% | 3,286 | +62.3% | 0.00% | – |
| Q1 2016 | $5,000 | -61.5% | 2,025 | +25.1% | 0.00% | – |
| Q4 2015 | $13,000 | +225.0% | 1,619 | +161.6% | 0.00% | – |
| Q3 2015 | $4,000 | -20.0% | 619 | 0.0% | 0.00% | – |
| Q2 2015 | $5,000 | 0.0% | 619 | 0.0% | 0.00% | – |
| Q1 2015 | $5,000 | -16.7% | 619 | -27.9% | 0.00% | – |
| Q1 2014 | $6,000 | +50.0% | 859 | +35.3% | 0.00% | – |
| Q4 2013 | $4,000 | 0.0% | 635 | 0.0% | 0.00% | – |
| Q3 2013 | $4,000 | -55.6% | 635 | 0.0% | 0.00% | – |
| Q2 2013 | $9,000 | – | 635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |